Menu

European Medicines Agency to Move to Amsterdam

A coin toss decides the agency’s post-Brexit home once it departs from London.

Nov 20, 2017
Shawna Williams

ISTOCK, KARP85The European Medicines Agency (EMA), an organization that regulates drugs sold in the European Union for human and animal use, determined today (November 20) it will move from London to Amsterdam. The agency, which EU Observer reports employs 890 people, is making the move because of Britain’s decision to leave the E.U. in 2019. It has been based in London since 1995, the BBC reports.

Cities across Europe bid to be the new site for the EMA, which “promises to make its new host into a hub for Europe's medical industry,” the BBC notes. After three rounds of voting among EU ministers, Milan and Amsterdam were tied for the most votes, so the winner was decided by a coin toss. A vote on the new location for the European Banking Agency, also headquartered in London, is expected later today.

“The relocation of the E.M.A. away from London will be a bitter pill to swallow,” says Rory Palmer, a spokesperson for the UK Labour Party’s lawmakers in the European Parliament, in a statement to the New York Times. “Our economy will suffer. Our health sector will suffer. Our successful pharmaceutical industry will suffer.”

Halbe Zijlstra, the Netherlands’s foreign affairs minister, took a sunnier view, tweeting, “Good for the Netherlands and above all good for EU citizens who can continue to count on high-quality medicines & proper supervision. It shows we can tackle effects of Brexit with resolve.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.